Evidence map›Paper›PMID 29779898›Full record

ArticleStem cell reports2018

Oncostatin M and Kit-Ligand Control Hematopoietic Stem Cell Fate during Zebrafish Embryogenesis.

Christopher B Mahony, Corentin Pasche, Julien Y Bertrand

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Haematopoiesis in Zebrafish (Danio Rerio).Frontiers in immunology · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Modeling hematopoietic disorders in zebrafish.Disease models & mechanisms · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher B MahonyUniversity of Geneva, Faculty of Medicine, Department of Pathology and Immunology, CMU, University of Geneva, 1 Rue Michel-Servet, Geneva 1211, Switzerland.
Corentin PascheUniversity of Geneva, Faculty of Medicine, Department of Pathology and Immunology, CMU, University of Geneva, 1 Rue Michel-Servet, Geneva 1211, Switzerland.
Julien Y BertrandUniversity of Geneva, Faculty of Medicine, Department of Pathology and Immunology, CMU, University of Geneva, 1 Rue Michel-Servet, Geneva 1211, Switzerland. Electronic address: julien.bertrand@unige.ch.
University of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the molecular pathways controlling hematopoietic stem cell specification and expansion is a necessary milestone to perform regenerative medicine. Here, we used the zebrafish model to study the role of the ckit signaling pathway in this process. We show the importance of kitb/kitlgb signaling in the specification and expansion of hematopoietic stem cells (HSCs), in the hemogenic endothelium and caudal hematopoietic tissue (CHT), respectively. Moreover, we identified the zebrafish ortholog of Oncostatin M (osm) in the zebrafish genome. We show that the osm/osmr pathway acts upstream of kitb during specification of the hemogenic endothelium, while both pathways act synergistically to expand HSCs in the CHT. Moreover, we found that osm, in addition to its role in promoting HSC proliferation, inhibits HSC commitment to the lymphoid fate. Altogether, our data identified two cytokines, kitlgb and osm, secreted by the vascular niche, that control HSCs during early embryonic development.

Indexed as

ZebrafishAnimalsBiomarkersEmbryonic DevelopmentGene ExpressionHematopoietic Stem CellsImmunohistochemistryLymphocytesModels, BiologicalOncostatin MOncostatin M Receptor beta SubunitSignal TransductionStem Cell FactorBiomarkersOncostatin MOncostatin M Receptor beta SubunitStem Cell FactorcKIThematopoietic nichehematopoietic stem cellsKit-ligandoncostatin Moncostatin M receptor (osmr)zebrafish

Identifiers

PMID29779898
PMCPMC5993650
OpenAlexW2804733175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.